If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Recharged hopes of Brexit deal, trade truce power UK shares

Thu, 10th Oct 2019 09:40

* FTSE 100, FTSE 250 up 0.3%

* Mondi reverses course to close higher

* Miners biggest boost to main index

* FTSE 100 confirms "Death Cross" pattern
(Adds company news items, updates share moves, changes analyst
comments)

By Muvija M and Shashwat Awasthi

Oct 10 (Reuters) - London stocks finished a roller coaster
session on Thursday with gains as domestic companies rose after
Britain and Ireland said they saw a pathway to a Brexit deal,
and international names jumped on to a global rally over hopes
of a U.S.-China trade truce.

The FTSE 100 ended 0.3% higher, after flipping back
and forth during the day on mixed signals over the state of
affairs between Beijing and Washington, while the midcap index
that has a greater UK exposure also rose by the same level.

However, a more than 1% surge in sterling on renewed
prospects of a Brexit agreement kept a lid on gains for the
blue-chip bourse, which earns a sizeable portion of its earnings
in the U.S. dollar.

Spirits company Diageo, consumer goods giant
Unilever and AstraZeneca were among stocks
hammered the most, causing the FTSE 100 to lag other major
indexes.

Stocks vulnerable to a hit from Brexit, on the other hand,
overpowered those losses. Lloyds topped the main board
with a 4% leap, while Royal Bank of Scotland added 3%.

Mining heavyweights, which rely on world's top metals
consumer China for a chunk of their profits, were the biggest
sector-wise boost to the main bourse, climbing 2.5% - their most
since early August.

Gains were triggered as hopes of a resolution to a painfully
long trade war returned after U.S. President Donald Trump said
he will meet Chinese Vice Premier Liu He on Friday.

The comments were well received, given they came after
sentiment had turned sour following a report that Beijing has
urged Washington to stop unreasonable pressure on Chinese
companies.

On news-related moves, FTSE 100 component Mondi
reversed earlier losses to close 2% higher after a third-quarter
update, while homewares retailer Dunelm slumped 10% to
the bottom of the midcap index after it flagged a softer market.

Still, reflecting recent worries over trade and Brexit, the
FTSE 100 confirmed a "Death Cross" pattern as its 50-day moving
average (DMA) crossed below the 200 DMA, which is seen a warning
sign that more losses are likely in the near term.

The blue-chip bourse last formed the pattern roughly a year
ago when Brexit negotiations and Italy's budget deficit had hit
risk appetite.

"The ebb and flow of sentiment around U.S., China trade
continues to pull global stock markets from pillar to post," CMC
Markets' Michael Hewson wrote.

(Reporting by Muvija M and Shashwat Awasthi in Bengaluru;
Editing by Bernard Orr and Giles Elgood)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.